Emglif™-LM XR

Therapeutic Segment:
Anti-diabetic

Generic Name:
Empagliflozin/Linagliptin/Metformin HCl

Description:
Emglif™-LM XR tablets contain three oral antihyperglycemic drugs used in the management of type 2 diabetes: Linagliptin, Empagliflozin and Metformin HCL.

Indication:
This medication is a combination of empagliflozin, linagliptin, and metformin hydrochloride (HCl) indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.

Formulation: